<DOC>
	<DOCNO>NCT02545829</DOCNO>
	<brief_summary>The purpose study investigate bioequivalence administration HIP1302 HGP1406 healthy male volunteer .</brief_summary>
	<brief_title>Evaluating Bioequivalence HIP1302 , HGP1406</brief_title>
	<detailed_description>A Randomized , Open , 2-way cross-over , Single dose study Evaluate Compare Safety Pharmacokinetics HIP1302 HGP1406 Healthy Korean Male Volunteers</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Healthy male volunteer , age 19 50 year The result Body Mass Index ( BMI ) less 18.0 kg/m2 , 27.0 kg/m2 Subjects ability comprehend objective , content study property study drug participate trial willingness sign inform consent write Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>